The clinical diagnostic testing services support and accelerate the market entry of new drugs, vaccines and antivirals, and assist in pre- and post marketing surveillance programs. Services are customized to specific needs, enabling maximum flexibility from day-to-day analysis to high throughput bulk analysis.
Efficacy and safety assays target protective immunological responses, assess viral loads and monitor drug resistance. In association with the assay development department, clinical diagnostic services offer tailor-made solutions in consultation with the sponsor in order to complete the study as efficiently as possible.
Through state of the art BSL2 and BSL3 containment facilities and qualified biotechnical staff we are able to test immunogenicity and efficacy of vaccines, antivirals, antibodies and other products aimed at preventing or treating virus infections. In addition we have a broad range of validated molecular assays available ranging from simple PCR analysis to sensitive sequence analysis directly from the clinical sample.
All analyses are performed according to ISO 15189 accreditation.